Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CorMedix (CRMD) Non Operating Investment Income (2016 - 2025)

CorMedix has reported Non Operating Investment Income over the past 6 years, most recently at $2.3 million for Q4 2025.

  • Quarterly results put Non Operating Investment Income at $2.3 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $5.4 million (changed N/A YoY), and the annual figure for FY2025 was $5.4 million, changed.
  • Non Operating Investment Income reached $2.3 million in Q4 2025 per CRMD's latest filing, down from $3.1 million in the prior quarter.
  • Across five years, Non Operating Investment Income topped out at $3.1 million in Q3 2025 and bottomed at $2.3 million in Q4 2025.